Small molecule modulators of amine oxidation, nuclear receptor signaling and glucuronidation : 3-phenylcoumarin as a scaffold of interest
The costs of the drug development process are moderated as computer-aided
drug design methods are able to expedite the steps required for lead
identification. In fact, computational tools are nowadays virtually indispensable
from target identification and validation to preclinical tests due to exponential
growth of available information regarding both potential targets and small
molecules. One such small molecule with growing number of variations is
coumarin. Coumarin scaffold and its various derivatives continue to interest
researchers for their vast application potential. Since naturally occurring
coumarins are known for example for their antioxidant and anti-inflammatory
properties, those molecules are used to guide research endeavors toward similar
molecules but with enhanced or newly directed activities. In this doctoral thesis,
coumarin derivatives are used to gain novel details regarding monoamine
oxidase and nuclear receptor modulation in context relevant for example in
neurological conditions and cancer. In order to achieve this, diverse collection of
coumarin derivatives is investigated in these targets and corresponding
antitargets using both computational and experimental methods. As a result,
novel coumarin derivatives with activity in nanomolar range are identified in
case of monoamine oxidase B and estrogen receptor ǂ and comparable activity is
reached for retinoid-acid-receptor-related orphan receptor DŽt with novel core. In
addition, the usability of coumarin derivatives as assay development tools is put
to test by designing selective ligands for glucuronidation. Consequently, the
metabolic fate of the coumarins is investigated as they are allocated to
metabolizing target using homology models, computational methods and
experimental techniques. Subsequently, two coumarin derivatives selective for
human uridine 5'-diphospho-glucuronosyltransferase 1A10 are identified.
...
Publisher
University of JyväskyläISBN
978-951-39-7397-1ISSN Search the Publication Forum
1456-9701Contains publications
- Artikkeli I: Rauhamäki S., Postila P.A., Niinivehmas S., Kortet S., Schildt E., Pasanen M., Manivannan E., Ahinko M., Koskimies P., Nyberg N., Huuskonen P., Multamäki E., Pasanen M., Juvonen R.O., Raunio H., Huuskonen J. & Pentikäinen O.T. 2018. Structure-Activity Relationship Analysis of 3- phenylcoumarin-Based Monoamine Oxidase B Inhibitors. Frontiers in Chemistry 6: 41. DOI: 10.3389/fchem.2018.00041.
- Artikkeli II: Niinivehmas S., Manivannan E., Rauhamäki S., Huuskonen J. & Pentikäinen O.T. 2016. Identification of estrogen receptor α ligands with virtual screening techniques. Journal of Molecular Graphics and Modeling 64: 30–39. DOI: 10.1016/j.jmgm.2015.12.006.
- Artikkeli III: Niinivehmas S., Postila P.A., Rauhamäki S., Manivannan E., Kortet S., Ahinko M., Huuskonen P., Nyberg N., Koskimies P., Lätti S., Multamäki E., Juvonen R.O., Raunio H., Pasanen M., Huuskonen J. & Pentikäinen O.T. 2018. Blocking oestradiol synthesis pathways with potent and selective coumarin derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry. DOI: 10.1080/14756366.2018.1452919.
- Artikkeli IV: Rauhamäki S., Postila P.A., Lätti S., Niinivehmas S., Multamäki E., Liedl K. & Pentikäinen O.T. 2018. Discovery of Retinoic Acid-Related Orphan Receptor DŽt Inverse Agonists via Docking and Negative Image-Based Screening Submitted manuscript.
- Artikkeli V: Juvonen R.O., Rauhamäki S., Kortet S., Niinivehmas S., Troberg J., Petsalo A., Huuskonen J., Raunio H., Finel M. & Pentikäinen O.T. 2018. Molecular Docking-Based Design and Development of a Highly Selective Probe Substrate for UDP-glucuronosyltransferase 1A10. Molecular Pharmaceutics 15: 3: 923–933. DOI: 10.1021/acs.molpharmaceut.7b008712.
Keywords
Metadata
Show full item recordCollections
- Väitöskirjat [3602]
License
Related items
Showing items with similar title or keywords.
-
Structure-Activity Relationship Analysis of 3-phenylcoumarin-Based Monoamine Oxidase B Inhibitors
Rauhamäki, Sanna; Postila, Pekka; Niinivehmas, Sanna; Kortet, Sami; Schildt, Emmi; Pasanen, Mira; Manivannan, Elangovan; Ahinko, Mira; Koskimies, Pasi; Nyberg, Niina; Huuskonen, Pasi; Multamäki, Elina; Pasanen, Markku; Juvonen, Risto O.; Raunio, Hannu; Huuskonen, Juhani; Pentikäinen, Olli (Frontiers Media S.A., 2018)Monoamine oxidase B (MAO-B) catalyzes deamination of monoamines such as neurotransmitters dopamine and norepinephrine. Accordingly, small-molecule MAO-B inhibitors potentially alleviate the symptoms of dopamine-linked ... -
Estrogen regulates muscle bioenergetic signaling
Laakkonen, Eija; Soliymani, Rabah; Lalowski, Maciej (Impact Journals, LLC, 2018) -
New spiro-indeno[1,2-b]quinoxalines clubbed with benzimidazole scaffold as CDK2 inhibitors for halting non-small cell lung cancer; stereoselective synthesis, molecular dynamics and structural insights
Barakat, Assem; Alshahrani, Saeed; Al-Majid, Abdullah Mohammed; Alamary, Abdullah Saleh; Haukka, Matti; Abu-Serie Marwa, M.; Domingo, Luis R.; Ashraf, Sajda; Ul-Haq, Zaheer; Nafie, Mohamed S.; Teleb, Mohamed (Informa Healthcare, 2023)Despite the crucial role of CDK2 in tumorigenesis, few inhibitors reached clinical trials for managing lung cancer, the leading cause of cancer death. Herein, we report combinatorial stereoselective synthesis of rationally ... -
Activation of p53 signaling and regression of breast and prostate carcinoma cells by spirooxindole-benzimidazole small molecules
Barakat, Assem; Alshahrani, Saeed; Al-Majid, Abdullah Mohammed; Alamary, Abdullah Saleh; Haukka, Matti; Abu-Serie, Marwa, M.; Dömling, Alexander; Domingo, Luis, R.; Elshaier, Yaseen A. M. M. (Frontiers Media SA, 2024)This study discusses the synthesis and use of a new library of spirooxindole-benzimidazole compounds as inhibitors of the signal transducer and activator of p53, a protein involved in regulating cell growth and cancer ... -
Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments
Hulmi, Juha J.; Nissinen, Tuuli A.; Penna, Fabio; Bonetto, Andrea (MDPI, 2021)Muscle wasting, i.e., cachexia, frequently occurs in cancer and associates with poor prognosis and increased morbidity and mortality. Anticancer treatments have also been shown to contribute to sustainment or exacerbation ...